SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005161
Filing Date
2020-05-05
Accepted
2020-05-05 15:18:02
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q imgn-20200505x10q.htm   iXBRL 10-Q 1046857
2 EX-10.1 imgn-20200331xex10d1.htm EX-10.1 203399
3 EX-31.1 imgn-20200331xex31d1.htm EX-31.1 11565
4 EX-32 imgn-20200331xex32.htm EX-32 7820
  Complete submission text file 0001558370-20-005161.txt   5787902

Data Files

Seq Description Document Type Size
5 EX-101.SCH imgn-20200505.xsd EX-101.SCH 48547
6 EX-101.CAL imgn-20200505_cal.xml EX-101.CAL 35958
7 EX-101.DEF imgn-20200505_def.xml EX-101.DEF 187673
8 EX-101.LAB imgn-20200505_lab.xml EX-101.LAB 469823
9 EX-101.PRE imgn-20200505_pre.xml EX-101.PRE 341307
16 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20200505x10q_htm.xml XML 939057
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 20848554
SIC: 2834 Pharmaceutical Preparations